Compare MXCT & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | ACU |
|---|---|---|
| Founded | 1999 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.0M | 160.6M |
| IPO Year | 2021 | 1994 |
| Metric | MXCT | ACU |
|---|---|---|
| Price | $1.11 | $54.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.50 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.7M | 14.4K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 1.63 |
| EPS | N/A | ★ 0.24 |
| Revenue | $33,026,000.00 | ★ $196,541,816.00 |
| Revenue This Year | N/A | $5.67 |
| Revenue Next Year | $18.50 | $5.25 |
| P/E Ratio | ★ N/A | $218.54 |
| Revenue Growth | N/A | ★ 1.05 |
| 52 Week Low | $0.64 | $35.50 |
| 52 Week High | $2.31 | $52.82 |
| Indicator | MXCT | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 38.61 | 75.21 |
| Support Level | $1.08 | $39.97 |
| Resistance Level | $1.16 | N/A |
| Average True Range (ATR) | 0.09 | 1.92 |
| MACD | -0.03 | 0.41 |
| Stochastic Oscillator | 6.10 | 87.06 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.